Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Oral contraceptives may cause hair loss in women.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Hormones and genes affect hair growth and male baldness.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Finasteride caused enlarged breast tissue in a 62-year-old man.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Balding men had lower bone density, while balding women had higher hip bone density.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Plant-based products can improve hair and skin health without harmful side effects.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

The safety of placental and umbilical extracts in cosmetics is uncertain, requiring more research.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Sex steroids, especially progesterone, can slow down the growth of mouse melanoma cells.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The document concludes that awareness and understanding of hidradenitis suppurativa are increasing, but effective treatments are still needed.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.